Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.0T | 1.2T | 1.1T | 1.0T |
Cost of revenue | 668.9B | 764.0B | 694.2B | 622.4B |
Gross profit | 369.0B | 397.3B | 434.1B | 383.0B |
Operating expense | ||||
Research & development | 25.2B | 22.4B | 27.7B | 29.5B |
Selling general and admin | — | — | — | — |
Other operating expenses | 205.2B | -13.6B | 244.0B | 208.3B |
Operating income | -33.3B | 55.2B | -4.3B | -22.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 9.4B | -7.6B | 17.3B | 20.3B |
Other income expense | — | — | — | — |
Pretax income | 55.6B | 114.7B | 76.7B | 57.7B |
Tax provision | 15.6B | 29.1B | 21.0B | 23.2B |
Net income | 40.0B | 134.3B | 55.8B | 34.5B |
Basic EPS | 10.7 | — | 14.8 | 9.7 |
Diluted EPS | 10.7 | — | 14.8 | 9.7 |
Basic average shares | 3.7B | — | 3.7B | 3.4B |
Diluted average shares | 3.7B | — | 3.7B | 3.4B |
EBITDA | 118.8B | 161.1B | 148.3B | 138.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | -790M | 410M | -1.3B | -1.1B |
Preferred stock dividends | 0 | 0 | 0 | 0 |